Cardiff Oncology, Inc. CRDF · Stock Open Cardiff Oncology, Inc. in new tab
Analyst price targets
Recent rating changes, newest first
Cardiff Oncology, Inc. Analysis (CRDF)
Is Cardiff Oncology, Inc. a good investment? Cardiff Oncology, Inc. (CRDF) is currently trading at 0.9100 USD. Market analysts have a consensus price target of 5.81 USD. This suggests a potential upside from current levels.
Earnings Schedule: Cardiff Oncology, Inc. is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is -0.54.
Investor FAQ
Does Cardiff Oncology, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Cardiff Oncology, Inc.?
Cardiff Oncology, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of -0.59.
Company Profile
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with FOLFIRI and bevacizumab or FOLFOX and bevacizumab for the treatment of patients confirmed metastatic and unresectable colorectal cancer in patients with a KRAS or NRAS mutation; and TROV-054, a Phase 1b/2 single-arm clinical trial in KRAS-mutated metastatic colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
| Split Date | Split Ratio to 1 |
|---|---|
| July 27, 2004 | 111:1 |
| May 30, 2012 | 1:6 |
| June 4, 2018 | 1:12 |
| Feb. 20, 2019 | 1:6 |
Community Discussion